Ishares Biotechnology Etf Buy Hold or Sell Recommendation
| IBB Etf | USD 136.10 1.26 0.93% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding iShares Biotechnology ETF is 'Strong Hold'. Macroaxis provides IShares Biotechnology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IBB positions.
Check out IShares Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual funds such as IShares and provide practical buy, sell, or hold recommendation based on investors' investing horizon and their risk tolerance towards iShares Biotechnology ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
IShares |
Execute IShares Biotechnology Buy or Sell Advice
The IShares recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on iShares Biotechnology ETF. Macroaxis does not own or have any residual interests in iShares Biotechnology ETF or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute IShares Biotechnology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details |
IShares Biotechnology Trading Alerts and Improvement Suggestions
| IShares Biotechnology generated a negative expected return over the last 90 days | |
| Latest headline from zacks.com: Should You Invest in the Invesco Biotechnology Genome ETF | |
| The fund generated three year return of -4.0% | |
| iShares Biotechnology ETF retains 99.93% of its assets under management (AUM) in equities |
IShares Biotechnology Returns Distribution Density
The distribution of IShares Biotechnology's historical returns is an attempt to chart the uncertainty of IShares Biotechnology's future price movements. The chart of the probability distribution of IShares Biotechnology daily returns describes the distribution of returns around its average expected value. We use iShares Biotechnology ETF price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of IShares Biotechnology returns is essential to provide solid investment advice for IShares Biotechnology.
| Mean Return | -0.13 | Value At Risk | -1.7 | Potential Upside | 1.55 | Standard Deviation | 1.11 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of IShares Biotechnology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
IShares Biotechnology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to IShares Biotechnology or iShares sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that IShares Biotechnology's price will be affected by overall etf market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a IShares etf's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.22 | |
β | Beta against Dow Jones | 0.96 | |
σ | Overall volatility | 1.13 | |
Ir | Information ratio | -0.2 |
IShares Biotechnology Volatility Alert
iShares Biotechnology ETF exhibits very low volatility with skewness of -1.26 and kurtosis of 3.72. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure IShares Biotechnology's etf risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact IShares Biotechnology's etf price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.IShares Biotechnology Fundamentals Vs Peers
Comparing IShares Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze IShares Biotechnology's direct or indirect competition across all of the common fundamentals between IShares Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as IShares Biotechnology or determine the etfs which would be an excellent addition to an existing portfolio. Peer analysis of IShares Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing IShares Biotechnology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare IShares Biotechnology to competition |
| Fundamentals | IShares Biotechnology | Peer Average |
| Price To Earning | 3.16 X | 3.15 X |
| Price To Book | 3.39 X | 0.39 X |
| Price To Sales | 4.94 X | 0.33 X |
| Beta | 0.85 | |
| One Year Return | 13.70 % | (0.97) % |
| Three Year Return | (4.10) % | 3.23 % |
| Five Year Return | 3.70 % | 1.12 % |
| Ten Year Return | 3.40 % | 1.20 % |
| Net Asset | 7.41 B | 2.29 B |
| Last Dividend Paid | 0.39 | 0.14 |
| Equity Positions Weight | 99.93 % | 52.82 % |
IShares Biotechnology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as IShares . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 28543.94 | |||
| Daily Balance Of Power | 0.4214 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 135.12 | |||
| Day Typical Price | 135.44 | |||
| Price Action Indicator | 1.61 | |||
| Period Momentum Indicator | 1.26 | |||
| Relative Strength Index | 31.46 |
About IShares Biotechnology Buy or Sell Advice
When is the right time to buy or sell iShares Biotechnology ETF? Buying financial instruments such as IShares Etf isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having IShares Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Realty Funds Thematic Idea Now
Realty Funds
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out IShares Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
The market value of iShares Biotechnology ETF is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is IShares Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Biotechnology's market value can be influenced by many factors that don't directly affect IShares Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.